QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.60
+1.82% today
Updated 2026-04-30
Market cap
$83.68M
P/E ratio
2.36
P/S ratio
1.56x
EPS (TTM)
$2.42
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Q32 Bio Inc (QTTB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+69.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+494.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+12.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+35.5%
2026-03-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $4.58 | +632.6% | $5.10 | $6.91 | +35.5% |
| 2025-11-13 | $-0.60 | +49.6% | $2.43 | $2.16 | -11.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.86 | $4.58 | +632.6% | $53.74M | — |
| 2025-09-30 | $-1.19 | $-0.60 | +49.6% | — | — |
| 2025-06-30 | $-0.80 | $-0.78 | +2.5% | — | — |
| 2025-03-31 | $-1.23 | $-0.90 | +26.8% | — | — |
| 2024-12-31 | $-1.53 | $-1.16 | +24.2% | — | — |
| 2024-09-30 | $-1.40 | $-1.46 | -4.1% | — | — |
| 2024-06-30 | $-1.04 | $-1.42 | -36.5% | — | — |
| 2024-03-31 | $-2.32 | $-14.95 | -544.4% | — | — |
| 2023-12-31 | $-0.30 | $-0.28 | +6.7% | $-14.66M | — |
| 2023-09-30 | $-0.43 | $-0.57 | -32.6% | $1.86M | — |
| 2023-06-30 | $-0.50 | $-0.61 | -22.0% | $3.21M | — |
| 2023-03-31 | $-0.52 | $-0.50 | +3.8% | $2.95M | — |
Frequently asked questions
Has Q32 Bio Inc beaten earnings estimates?
Q32 Bio Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +69.7% over the last 4 quarters.
How does QTTB stock react to earnings?
QTTB stock has moved an average of +12.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.